Hostname: page-component-7b7567c8c-7pwfn Total loading time: 0 Render date: 2026-11-17T03:35:41.910Z Has data issue: false hasContentIssue false

The Effect of Plasmapheresis on Post-Thymectomy Ocular Dysfunction

Published online by Cambridge University Press:  18 September 2015

C.W. Olanow*
Affiliation:
Department of Medicine (Division of Neurology), Howard Hughes Medical Institute; Department of Medicine (Division of Hematology-Oncology), Duke University Medical Center, Durham, North Carolina
A.D. Roses*
Affiliation:
Department of Medicine (Division of Neurology), Howard Hughes Medical Institute; Department of Medicine (Division of Hematology-Oncology), Duke University Medical Center, Durham, North Carolina
J.W. Fay*
Affiliation:
Department of Medicine (Division of Neurology), Howard Hughes Medical Institute; Department of Medicine (Division of Hematology-Oncology), Duke University Medical Center, Durham, North Carolina
*
Department of Medicine (Neurology), Duke University Medical Center, Durham. North Carolina, USA. 27710
Department of Medicine (Neurology), Duke University Medical Center, Durham. North Carolina, USA. 27710
Department of Medicine (Neurology), Duke University Medical Center, Durham. North Carolina, USA. 27710
Rights & Permissions [Opens in a new window]

Summary:

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the 'Save PDF' action button.

Five myasthenia gravis patients with post-thymectomy residual ocular signs were treated with plasmapheresis. Despite a significant reduction in AChR antibody titer, there was no clinical improvement. Subsequently, there was a dramatic response to prednisone. The AChR antibody titer did not correlate with the clinical state of the individual patient. It is suggested that plasmapheresis may operate by removing a thymic factor and that prednisone acts by a different mechanism.

Information

Type
Articles
Copyright
Copyright © Canadian Neurological Sciences Federation 1981